FX Conferences is proud to be the leader in providing convenient distance learning opportunities designed for busy professionals. We partner with leading industry experts to bring you key information and guidance on the latest challenges and hot topics, and our audio conference format makes it easy to participate from the office, at home or on the road. Feel free to browse through our list of coming events, or use our search feature to review past live presentations now available as recordings.

Search By
Industry
Department

Optimizing Your Chemistry, Manufacturing & Control Program

Audio conference highlights


Chemistry, Manufacturing, and Controls (CMC) programs are an integral part of the development process which brings a drug from the preclinical phase to the market. Without a CMC program that is properly integrated with the clinical, non-clinical, and marketing programs, the entire development cycle can be delayed, resulting in lost time, revenues and market life cycle. However, the extent of necessary activities in CMC programs can vary depending on the development phase of the drug.


This audio conference explores how the skillful combination of drug characterization, manufacturing and packaging processes, analytical test methodology, compliance with applicable regulations and adequate documentation all help to ensure that the CMC portions of an application meet the necessary requirements, as well as supporting the clinical and nonclinical studies being performed to establish the safety and efficacy of the drug.


This audio conference covers:


  • Components of CMC programs
  • CMC activities at various phases of development
  • General CMC activities for drug substances
  • Compliance activities for CMC programs
  • General CMC activities for drug products


About the speaker:


Miguel de Soto-Perera, PhD, is Vice President of Pharmaceutical Sciences at Beckloff Associates, Inc. (BAI). He holds a Doctorate in Electroanalytical Chemistry and a Master’s Degree in Analytical Chemistry, both from the University of Massachusetts at Amherst, and has nearly 30 years of experience in the pharmaceutical industry. He also has extensive teaching experience at the undergraduate and graduate levels, and is a regular lecturer at regulatory workshops offered by BAI, both domestically and internationally.


Dr. de Soto-Perera began his career as Senior Analytical Chemist with Dow Chemical before joining BAI in 1995. His responsibilities at BAI have specifically included performing cGMP audits and developing cGMP compliance programs for APIs and drug products in various countries. In his current position, he is responsible for all the managerial, business, and technical aspects of one of the Chemistry, Manufacturing, and Control (CMC) groups, which includes personnel located in offices in Overland Park, KS and San Diego, CA.


Who should attend?


  • CMC Specialists
  • Quality Assurance & Quality Control
  • Regulatory Affairs
  • Research & Development
  • Operations Managers


Speaker & Time

Dr. Miguel de Soto-Perera, Beckloff Associates, Inc.
Optimizing Your Chemistry, Manufacturing & Control Program
Title: Vice President of Pharmaceutical Sciences
Duration: 60 minutes
Discount: Buy 2 items, get 25% off your order using coupon code FX25%OFF
Event Type: Previously recorded on 2009-06-10
Item #: ac20090610
10 Jun 2009 
Registration Price:
$249.00

Order Info

Select Order Type:  
Include Transcript With Order?:  
Quantity
More
Less
 
 
Bookmark and Share reviews

Reviews

Average Rating: (based on 1 review)

Showing 1 Review:

by T.W.
Quality Assurance Associate
This was an excellent high-level overview of CMC activities. This is great for all CMC employees, especially new ones in the pharmaceutical industry.
Rate this item
Similar Events
Regulatory and Scientific Considerations for API Drug Development
Dr. William (Trey) Putnam, Beckloff Associates, Inc. (a Cardinal Health company)
More about Regulatory and Scientific Considerations for API Drug Development


More about Drug Establishment Registrations, Drug Listings and the FDA Electronic Submissions Gateway


More about Electronic Submissions in Europe – eCTD and non-eCTD Submissions (NeeS)

 
Recently Viewed
QA Oversight of Contract Manufacturers
Marion Weinreb, Marion Weinreb & Associates, Inc.
More about QA Oversight of Contract Manufacturers


Selecting a Phase I Clinical Trial Site
Lorraine S. DeCesare, LS Drug Development, Inc.
More about Selecting a Phase I Clinical Trial Site


Best Practices for Managing In-Country Translation Reviews
Andres Heuberger, ForeignExchange Translations, Inc.
More about Best Practices for Managing In-Country Translation Reviews

© Copyright 2010
ForeignExchange Translations.
All rights reserved.

Home  |   FAQ  |   Blog  |   Translation Services  |   Search  |   Privacy Policy  |   Terms of Use  |   Contact Us